Search

Author/Creator Vence, Luis

1. Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer. (4th November 2015)

Authors:
Subudhi, Sumit K; Aparicio, Ana; Gao, Jianjun; Zurita, Amado; John, Araujo; Logothetis, Christopher; Rao, Brinda; Vence, Luis; Allison, James; Emerson, Ryan O; Yusko, Erik; Vignali, Marissa; Robins, Harlan; Sun, Jing Jing; Sharma, Padmanee
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer. Issue 2 (December 2015)

Authors:
Subudhi, Sumit; Aparicio, Ana; Gao, Jianjun; Zurita, Amado; John, Araujo; Logothetis, Christopher; Rao, Brinda; Vence, Luis; Allison, James; Emerson, Ryan; Yusko, Erik; Vignali, Marissa; Robins, Harlan; Sun, Jing; Sharma, Padmanee
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Issue 4 (April 2017)

Authors:
Morris, Van K; Salem, Mohamed E; Nimeiri, Halla; Iqbal, Syma; Singh, Preet; Ciombor, Kristen; Polite, Blase; Deming, Dustin; Chan, Emily; Wade, James L; Xiao, Lianchun; Bekaii-Saab, Tanios; Vence, Luis; Blando, Jorge; Mahvash, Armeen; Foo, Wai Chin; Ohaji, Chimela; Pasia, Manolo; Bland, Gail; Ohi...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 4(2017:Apr.)
Page Start:
446
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Issue 1 (18th April 2017)

Authors:
Reilley, Matthew J.; Bailey, Ann; Subbiah, Vivek; Janku, Filip; Naing, Aung; Falchook, Gerald; Karp, Daniel; Piha-Paul, Sarina; Tsimberidou, Apostolia; Fu, Siqing; Lim, JoAnn; Bean, Stacie; Bass, Allison; Montez, Sandra; Vence, Luis; Sharma, Padmanee; Allison, James; Meric-Bernstam, Funda; Hong, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 5:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report. Issue 1 (December 2016)

Authors:
Uemura, Marc; Trinh, Van; Haymaker, Cara; Jackson, Natalie; Kim, Dae; Allison, James; Sharma, Padmanee; Vence, Luis; Bernatchez, Chantale; Hwu, Patrick; Diab, Adi
Journal:
Journal of hematology & oncology
Issue:
Volume 9:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Issue 4 (22nd November 2019)

Authors:
de Groot, John; Penas-Prado, Marta; Alfaro-Munoz, Kristin; Hunter, Kathy; Pei, Be Lian; O'Brien, Barbara; Weathers, Shiao-Pei; Loghin, Monica; Kamiya Matsouka, Carlos; Yung, W K Alfred; Mandel, Jacob; Wu, Jimin; Yuan, Ying; Zhou, Shouhao; Fuller, Gregory N; Huse, Jason; Rao, Ganesh; Weinberg, Jef...
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 4(2020)
Page Start:
539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗